A07812 Summary:

BILL NOA07812
 
SAME ASNo Same As
 
SPONSORBraunstein
 
COSPNSR
 
MLTSPNSR
 
Add S3309-b, Pub Health L
 
Requires that for the first opioid analgesic prescription of a calendar year, the prescribing physician shall counsel the patient on the risks of overdose, and inform the patient of the availability of an opioid antagonist, including, but not limited to, naloxone.
Go to top    

A07812 Actions:

BILL NOA07812
 
05/27/2015referred to health
01/06/2016referred to health
Go to top

A07812 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          7812
 
                               2015-2016 Regular Sessions
 
                   IN ASSEMBLY
 
                                      May 27, 2015
                                       ___________
 
        Introduced  by  M.  of  A.  BRAUNSTEIN  -- read once and referred to the
          Committee on Health
 
        AN ACT to amend the public health law, in relation to  opioid  analgesic
          prescriptions
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The public health law is amended by adding  a  new  section
     2  3309-b to read as follows:
     3    § 3309-b. Opioid analgesic prescription. 1. For the first opioid anal-
     4  gesic  prescription of a calendar year that is greater than a one week's
     5  supply, the prescribing physician shall counsel the patient on the risks
     6  of overdose, and inform the patient of the  availability  of  an  opioid
     7  antagonist, including, but not limited to, naloxone.
     8    2.  For  the  purposes of this section, the following terms shall have
     9  the following meanings:
    10    (a) "Opioid analgesics" means the medicines  buprenorphine,  butorpha-
    11  nol,   codeine,  hydrocodone,  hydromorphone,  levorphanol,  meperidine,
    12  methadone, morphine, nalbuphine,  oxycodone,  oxymorphone,  pentazocine,
    13  propoxyphene as well as their brand names, isomers and combinations.
    14    (b) "Opioid antagonist" means an FDA-approved drug that, when adminis-
    15  tered,  negates  or  neutralizes in whole or in part the pharmacological
    16  effects of an opioid in the body. The opioid antagonist  is  limited  to
    17  naloxone  or  other  medications  approved  by  the  department for this
    18  purpose.
    19    § 2. This act shall take effect on the one hundred twentieth day after
    20  it shall have become a law; provided, however, that effective immediate-
    21  ly, the addition, amendment and/or repeal  of  any  rule  or  regulation
    22  necessary  for  the  implementation of this act on its effective date is
    23  authorized and directed to be made  and  completed  on  or  before  such
    24  effective date.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10787-03-5
Go to top